Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Regeneron Pharmaceuticals, Inc. is a biotechnology company that invents, develops, manufactures, and markets medicines for serious diseases across ophthalmology, immunology, oncology, and rare conditions. Its core technologies include proprietary antibody platforms and genetic research centers. The company collaborates globally, partners with other pharma firms, and leverages innovative research to bring targeted biologics and gene therapies to patients worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.